Founded in 2007, Acikang is the first company specializing in the research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates in China, and has created a new field of research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates in China. The company has 2800 square meters of R & D and pilot base and 50 acres of industrialization base. After eight years of investment and development, more than 3,000 manufacturable products have been developed, of which 18 core process technologies and new drug research and development achievements have applied for invention patents. The company's main products include fluorine-containing pharmaceutical intermediates, piperidine, piperazine, pyrrolidine, azazindole, amantadine, azazo spiro, azazo ring.
The company won the "2009 most dynamic Shanghai Technology Enterprise"; In 2010, won the second prize of the "Second Shanghai Invention Innovation Competition"; In 2012, he won the fourth Chinese Overseas Chinese Community Contribution Award (Innovation achievement); In 2012, he won the "Science and Technology Innovation Award" of Shanghai Zhangjiang High-tech Park. The company has completed the Ministry of Science and Technology and Shanghai SME Technology Innovation Fund project.
The company has established direct or indirect cooperation with more than 500 international customers, including the world's top ten biomedical companies, internationally renowned research institutes and universities; At the same time, the technologies and products developed by the company are also used in their own new drug research and development projects.